Package 0143-9396-01

Brand: cisatracurium besylate

Generic: cisatracurium besylate
NDC Package

Package Facts

Identity

Package NDC 0143-9396-01
Digits Only 0143939601
Product NDC 0143-9396
Description

1 VIAL in 1 CARTON (0143-9396-01) / 5 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2023-05-31
Brand cisatracurium besylate
Generic cisatracurium besylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "6c1a13e7-546c-4b06-8217-73f2c4b7ed57", "openfda": {"unii": ["80YS8O1MBS"], "rxcui": ["199212", "1730194"], "spl_set_id": ["c5a63679-0c94-4e9d-9ac0-8ee3023bd9a6"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0143-9396-01)  / 5 mL in 1 VIAL", "package_ndc": "0143-9396-01", "marketing_start_date": "20230531"}], "brand_name": "Cisatracurium Besylate", "product_id": "0143-9396_6c1a13e7-546c-4b06-8217-73f2c4b7ed57", "dosage_form": "INJECTION", "pharm_class": ["Neuromuscular Nondepolarizing Blockade [PE]", "Nondepolarizing Neuromuscular Blocker [EPC]"], "product_ndc": "0143-9396", "generic_name": "Cisatracurium Besylate", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Cisatracurium Besylate", "active_ingredients": [{"name": "CISATRACURIUM BESYLATE", "strength": "2 mg/mL"}], "application_number": "ANDA203078", "marketing_category": "ANDA", "marketing_start_date": "20230531", "listing_expiration_date": "20261231"}